What is the difference between short-acting and long-acting FDA-approved prescription sleeping pills in terms of morning grogginess and long-term tolerance buildup for budget-conscious patients?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the difference between short-acting and long-acting FDA-approved prescription sleeping pills in terms of morning grogginess and long-term tolerance buildup for budget-conscious patients?
3 real searches · 1 real-search pass
FDA prescription insomnia medications half-life next day impairment tolerance benzodiazepines Z-drugs label long term useGoogle ↗
OBSERVED
AASM clinical practice guideline pharmacologic treatment chronic insomnia tolerance dependence benzodiazepines zolpidem eszopiclone ramelteon doxepinGoogle ↗
OBSERVED
FDA drug safety communication insomnia medications next morning impairment zolpidem zaleplon eszopicloneGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
FDA prescription insomnia medications half-life next day impairment tolerance benzodiazepines Z-drugs label long term use Google ↗
AASM clinical practice guideline pharmacologic treatment chronic insomnia tolerance dependence benzodiazepines zolpidem eszopiclone ramelteon doxepin Google ↗
FDA drug safety communication insomnia medications next morning impairment zolpidem zaleplon eszopiclone Google ↗
- Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) · fda.gov
- Sleep Disorders (PDQ®) · cancer.gov
- Taking Z-drugs for Insomnia? Know the Risks · fda.gov
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline · pmc.ncbi.nlm.nih.gov
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians · doi.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA prescription insomnia medications half-life next day impairment tolerance benzodiazepines Z-drugs label long term use OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
AASM clinical practice guideline pharmacologic treatment chronic insomnia tolerance dependence benzodiazepines zolpidem eszopiclone ramelteon doxepin OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA drug safety communication insomnia medications next morning impairment zolpidem zaleplon eszopiclone OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |